Diamyd Medical AB (publ)
DYMDF
$0.73
$0.000.00%
OTC PK
| 05/31/2025 | 02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -16.72M | -16.02M | -14.76M | -14.32M | -13.10M |
| Total Depreciation and Amortization | 606.20K | 573.80K | 551.60K | 526.40K | 509.60K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -496.90K | -147.60K | 48.50K | 865.80K | 549.80K |
| Change in Net Operating Assets | 1.03M | 979.90K | 531.30K | 731.80K | -614.00K |
| Cash from Operations | -15.58M | -14.61M | -13.63M | -12.20M | -12.65M |
| Capital Expenditure | -831.70K | -417.70K | -712.10K | -756.20K | -923.70K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 4.43M | 700.90K | 700.90K | -1.85M | -3.69M |
| Cash from Investing | 3.60M | 282.90K | -11.50K | -2.60M | -4.61M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 315.39M | 105.32M | 105.32M | 135.21M | 210.48M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 1.17M | 13.72M | 14.14M | 7.08M | 19.19M |
| Cash from Financing | 31.77M | 11.24M | 11.28M | 13.16M | 21.32M |
| Foreign Exchange rate Adjustments | 447.40K | 122.40K | 43.40K | 14.40K | -18.70K |
| Miscellaneous Cash Flow Adjustments | -100.00 | -100.00 | 0.00 | 0.00 | -- |
| Net Change in Cash | 20.24M | -2.97M | -2.32M | -1.63M | 4.04M |